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The production by filamentous fungi of therapeutic glycoproteins intended for use in mammals is held back
by the inherent difference in protein N-glycosylation and by the inability of the fungal cell to modify proteins
with mammalian glycosylation structures. Here, we report protein N-glycan engineering in two Aspergillus
species. We functionally expressed in the fungal hosts heterologous chimeric fusion proteins containing
different localization peptides and catalytic domains. This strategy allowed the isolation of a strain with a
functional -1,2-mannosidase producing increased amounts of N-glycans of the Man5GlcNAc2 type. This strain
was further engineered by the introduction of a functional GlcNAc transferase I construct yielding
GlcNAcMan5GlcNac2 N-glycans. Additionally, we deleted algC genes coding for an enzyme involved in an early
step of the fungal glycosylation pathway yielding Man3GlcNAc2 N-glycans. This modification of fungal glyco-
sylation is a step toward the ability to produce humanized complex N-glycans on therapeutic proteins in
filamentous fungi.
Filamentous fungi belonging to the Aspergillus group are
well-established production hosts for extracellular enzymes of
industrial importance, such as amylases, glucoamylases, pectin-
ases, phytases, cellulases, and ligninases. (37). Glucoamylase
(1,4--D-glucan glucohydrolase; EC 3.2.1.3) is one of the most
prominent thermostable industrial enzymes (18) and is mainly
produced by Aspergillus niger fermentation. Typical fermenta-
tion yields by A. niger are up to 25 g/liter of glucoamylase (3).
In addition to homologous protein production, Aspergillus
nidulans, A. niger, and Aspergillus oryzae have offered an attrac-
tive alternative to Escherichia coli and yeasts, such as Saccha-
romyces cerevisiae, Kluyveromyces lactis, or Pichia pastoris, for
the expression of recombinant, heterologous proteins, and
there have been a number of attempts to program filamentous
fungi for the production of such heterologous proteins (13, 14,
20, 27, 29).
Whereas posttranslational modifications of secreted heter-
ologous proteins have been shown to influence protein stabil-
ity, yield, and function, the production by filamentous fungi of
therapeutic glycoproteins intended for use in mammals has
been hampered by the inherent difference in protein N-glyco-
sylation and by the inability of the fungal cell to modify pro-
teins with mammalian glycosylation structures. While both
fungi and mammals attach a specific oligosaccharide to aspar-
agines in the sequence Asn-X-Ser/Thr/Cys (where X repre-
sents any amino acid except proline), the subsequent process-
ing of the transferred glycan differs significantly between
mammalian and fungal cells (47). The assembly of a lipid-
linked oligosaccharide composed of three gluocose (Glc3),
nine mannose (Man9), and two N-acetylglucosamine (GlcNAc2)
residues (referred to as Glc3Man9GlcNAc2), followed by transfer
to the nascent protein and the removal of three glucose residues
and one mannose sugar to yield Man8GlcNAc2, is conserved
between eukaryotes. The biosynthetic glycosylation pathways di-
verge between fungi and mammals once a glycoprotein leaves the
endoplasmic reticulum (ER) and is shuttled through the Golgi
apparatus. Yeasts and other fungi typically produce high-man-
nose-type N-glycans by adding up to 100 mannose sugars,
including beta-linked mannoses and mannosylphosphates,
whereas the formation of mammalian glycans generally involves
the removal of mannose, followed by the addition of N-acetylglu-
cosamine, galactose, fucose, and sialic acid (8, 9, 25, 31). Recently,
glycoengineering in the yeast P. pastoris and the expression of
therapeutic glycoproteins with complex “humanized” N-glyco-
sylation structures have shown significant progress (4, 6, 10, 11,
15, 16, 26, 47). Far less progress has been made in glycoengi-
neering of fungal production hosts, such as Aspergillus or Tri-
choderma species, although the N-glycan structures of several
secreted glycoproteins have been elucidated.(1, 2, 17, 24, 28,
29, 34, 39–41, 48) and attempts were made to modify fungal
glycosylation structures by the insertion of glycan structure-
modifying enzymes (17, 29, 32). Introduction of rabbit
N-acetylglucosaminyltransferase I (GnT I) into A. nidulans has
resulted in the production of an in vitro active enzyme, but no
evidence for in vivo GlcNAc transfer was found (23). When
human cDNA encoding GnT I was expressed in Trichoderma
reesei, the incorporation of N-acetylglucoseamine into -1,3-
linked mannose of the core oligosaccharide Man5GlcNac2 was
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demonstrated by 1H nuclear magnetic resonance analysis, but
the efficiency of this incorporation was not analyzed (29). In
contrast to yeast species, hyperglycosylation is not a typical fea-
ture of filamentous fungi, which most often synthesize small high-
mannose-type N- and O-glycans (2). So far, no typical mamma-
lian-like complex-type glycans have been found or generated in
filamentous fungi (33). Some of the glycans found resemble mam-
malian high-mannose glycans [Man(6-9)GlcNAc2]. In addition,
typical “fungal-type” glycans that are structurally different from
the mammalian glycans have been identified on different Aspergil-
lus glycoproteins [Man(5-12)GlcNAc2] (1, 29, 44, 45).
Moreover, growth conditions have been found to influence
the glycan modification of some proteins, possibly by modulat-
ing the expression of enzymes involved in the fungal glyco-
sylation pathway (12).
In order to approach a solution for this important drawback
in the possibility of using fungal heterologous glycoproteins for
therapeutic applications (21, 28, 30), we used an approach
similar to that described for Pichia pastoris and systematically
engineered the glycosylation pathways of two Aspergillus spe-
cies. Here, we report the introduction of heterologous fusion
proteins, such as mannosidases and glycosyltransferases, as
well as the deletion of a gene (algC) coding for an enzyme
involved in an early step of the fungal glycosylation pathway.
MATERIALS AND METHODS
Strains. The A. nidulans and A. niger strains used throughout this work are
listed in Table 1 and Table 2, respectively. The strain T2 carries an expression
plasmid with a reporter protein and argB. This expression plasmid allows the
purification of the reporter protein (the C-terminal six-His-tagged K3 domain of
human plasminogen, as described in reference 6, and expressed from the A.
nidulans gpdA promoter) and and will allow analysis of the glycosylation of the
reporter protein in the future. E. coli strain JM 109 was used for routine plasmid
propagation.
Cloning of pEKgnopat. From plasmid pAN52-1 (38), the ATG of the A. nidulans
gpd promoter, as well as the NcoI site, was deleted by PCR using primers pAN52-
SalF (5-CGCAGACCGGGAACACAAGC-3) and pAN52-BamR (5-TAACGT
TAAGTGGATCCAAGCTGATGTCTGC-3). The resulting PCR fragment was
cloned as a SalI-BamHI fragment into the SalI/BamHI-cut pAN52-1 vector. The
NotI site of the vector pAN52-1 was deleted by partial digestion with NotI, filling in
of the protruding ends, and subsequent ligation. Cloning sites consisting of NcoI,
SwaI, AscI, and SbfI sites, as well as a PacI site, were introduced by cloning the
annealed oligonucleotides Not Pac F New (5-GATCCGCGGCCGCATTTAAAT
GGCGCGCCCCTGCAGGTTAATTAAG-3) and Not Pac R New(5-GATCCT
TAATTAACCTGCAGGGGCGCGCCATTTAAATGCGGCCGCG-3) as BamHI
fragments into the unique BamHI site of pAN52-1. Additionally, AsiSI, FseI, and
PmeI restriction sites were introduced by cloning the annealed oligonucleotides
pAN52 Marker F (5-TATGGCGATCGCGGCCGGCCGTTTAAACCA-3)
and pAN52 Marker R (5-TATGGTTTAAACGGCCGGCCGCGATCGCCA-
3) as NdeI fragments into the unique NdeI site of the vector, yielding the
expression vector pEKgnopat.
Cloning of the A. niger mnnJ leader sequence. The putative MnnJ protein
sequence was identified by a similarity search against the A. niger sequence
database (Integrated Genomics, Chicago, IL) using S. cerevisiae Mnn10p (acces-
sion number YDR245W) as a query sequence. Using the mnnJ sequence infor-
mation from the similarity search, the mnnJ leader sequence was amplified in a
5 rapid amplification of cDNA ends experiment with the specific primer RT
MNN10 (5-CTTCTCCCAGCTCTCGCGCCATTCG-3) and cloned into
pGEMT-easy for sequencing. The final leader sequence was amplified from the
pGEMT-easy plasmid using the forward primer An-MNN10-5 (5GCGGCCGC
CACCATGCTATTCCTCTTCCGTCGTTTCGAGCTG-3), creating a NotI re-
striction site (underlined), and the reverse primer An-MNN10-3 (5-GGCGCG
CCCCCATCGTTCCACATAATTCTTCTTGTTCCA-3), creating an AscI site
(underlined). The NotI-AscI fragments were used in subsequent cloning steps.
Cloning of -1,2-mannosidase genes into pEKgnopat. The -1,2-mannosidase
catalytic domain-leader fusions were cloned into the NotI-PacI-digested pEKgnopat
as NotI-PacI fragments. In the subsequent cloning step, the A. niger leader sequence
was cloned as NotI-AscI fragments into the NotI-AscI-digested vector.
Cloning of GlcNAc-transferase I genes into pEKgnopat. The GlcNAc-trans-
ferase I catalytic domain-leader fusions NA15 and coNA15 were obtained as a
gift from GlycoFi, Inc., in vectors pPB104 and pPB104-CO. coNA15 is a codon-
optimized sequence for expression in P. pastoris. To achieve this, the human
codons have been changed to the optimal P. pastoris codons following the codon
usage table available at http://www.kazusa.or.jp/codon/. The plasmids were con-
structed by fusion of sequences coding for amino acids 1 to 40 of ScMNN9 to
sequences coding for amino acids 38 to 445 of HsGNTI (Table 3) using the
nucleotide sequences GGGCGCGCC and GGAAGAGCA, respectively, as fu-
sion linkers in the process, adding the three amino acids GlyArgAla. In the case of
pPB104, this fusion was accomplished by using the AscI site created by the additional
nucleotides, and in the case of pPB104, the complete gene fusion sequence was
assembled using oligonucleotides and fusion PCR. Both fusions were then released
by NotI-PacI digestion and cloned into the NotI-PacI-digested pEKgnopat. Addi-
tionally, A. niger leader sequences were introduced into the pEKgnopat-NA15 plas-
mid by removing the MNN9 (no. 15) leader with a NotI-AscI digestion and cloning
the A. niger leader as NotI-AscI fragments into the vector.
algC knockout constructs. The putative algC protein sequence was identified
by a similarity search using S. cerevisiae Alg3p (accession number YBL082C) as
a query against the A. nidulans sequence database at Broad Institute (http://www
.broad.mit.edu) and the A. niger sequence database (Integrated Genomics, Chi-
cago, IL). Additional 3 and 5 sequence information on the algC gene of A. niger
was obtained by probing with the algC fragment a minilibrary based on restric-
tion site analysis of A. niger strain 888. A colony lift and subsequent hybridization
experiment with the algC PCR product as a probe revealed two clones that
yielded additional 3 sequence information. algC was knocked out by a DNA
fragment obtained by chimeric PCR. 3 and 5 fragments of the algC gene were
amplified from chromosomal A. niger DNA with the primer pairs alg3 F (5-G
TCACGGTCAACGTCCTCCCTCT-3) plus alg3_5primeR (5-CACAACCAC
CAGCGTGATCAAGTAGAG-3) and alg3_3primeF (5-GTTGCGATTAAG
ATGACACTGTTGCTG-3) plus alg3_3prime_R_new (5-GGAGGTGAATT
AGCTTGAGCGGAATA-3). An hph fragment with algC overhangs was
amplified from the vector pAN7 (38) using primers HmB_chimericF (5-CTCTA
CTTGATCACGCTGGTGGTTGTGTACACAGGCTCAAATCAATAAGAAG
TABLE 2. A. niger strains used throughout this work
Strain Genotypea Reference orsource




nicA1 cspA1 gpdAp-K3 This work
T2-BC10 nicA1 cspA1 amdS This work
T2-CD28 nicA1 cspA1 amdS This work
T2-BC10-coNA15 nicA1 cspA1 amdS hph This work
T2-BC10-mnnJ-NA nicA1 cspA1 amdS hph This work
T2-algC nicA1 cspA1 algC This work
a cspA1, morphological phenotype—short conidiophores; nicA1, nicotinic or
anthranilic acid requirement; amdS, amide nonutilization, acetamidase deficient;
hph, hygromycin B resistance; argB13, arginine requirement, OTCase deficient;
algC, altered glycosilation, Dol-P-Man:Man5GlcNAc2-PP-Dol mannosyltrans-
ferase deficient; gpdAp-K3, Kringle-3 domain of human plasminogen.
b FGSC, Fungal Genetics Stock Center (www.fgsc.net).
TABLE 1. A. nidulans strains used throughout this work
Strain Genotypea Reference
YR23.5 pyrG89 argB2 pantoA1 riboB2 This work
YR23.5-BC10 pyrG89 pantoA1 riboB2 This work
YR23.5-CD28 pyrG89 pantoA1 riboB2 This work
YR23.5-BC10-coNA15 pantoA1 riboB2 This work
YR23.5-mnnJ-NA pantoA1 riboB2 This work
YR23.5-algC pyrG89 pantoA1 riboB2 This work
a pyrG89, pyrimidine requirement, orotidine MP decarboxylase deficient;
argB2, arginine requirement, OTCase deficient; pantoA1, pantothenate require-
ment; riboB2, riboflavin requirement.
VOL. 74, 2008 ASPERGILLUS N-GLYCAN MODIFICATION 1077
AACG-3) and HmB_chimericR (5-CAGCAACAGTGTCATCTTAATCGCAA
CTAGATGTGGAGTGGGCGCTTACAC-3) and a long-run PCR kit (MBI
Fermentas). The three fragments were purified via gel excision and assembled in a
subsequent PCR, in which the overhangs of the hph fragment functioned as a
primer. Amplification of the chimeric PCR product was performed with the primers
alg3 F (5-GTCACGGTCAACGTCCTCCCTCT-3) and alg3_3prime_R_new (5-
GGAGGTGAATTAGCTTGAGCGGAATA-3). Fifteen microliters of the PCR
product was used directly for transformation.
To knock out the algC gene in A. nidulans, a recombinant DNA fragment was
constructed via chimeric PCR. 5 and 3 fragments of the algC gene were amplified
from chromosomal A. nidulans DNA with the primer pairs ANalgC5_fwd (5-GC
TGTTGGAGGCTCTGGATAGAAA-3) plus ANalgC5_rev (5-TGCCATTGTA
GTTGATGAAGAAGAAGA-3) and ANalgC3_fwd (5-GGACAACGTACATG
CAACAGGTCA-3) plus ANalgC3_rev (5-CCCGCGCAATTCCTTCTTTAG-
3). An argB fragment with algC overhangs was amplified from the vector pFB39
(43) using the primers chimeric-argB_fwd (5-CTCTTCTTCTTCATCAACTAC
AATGGCATATTTCGCGGTTTTTTGGGGTAGT-3) and chimeric-argB_rev
(5-TGACCTGTTGCATGTACGTTGTCCTAGCCATTGCGAAACCTCA
GAAG-3) and a long-run PCR kit (Roche). The three fragments were purified
and assembled in a subsequent PCR, in which the overhangs of the argB frag-
ment functioned as primers, and amplification of the chimeric nested PCR was
performed with the primers ANalgCnested_fwd (5-GTGTATGGAAACGAG
ACGATCATCTTC-3) and ANalgCnested_rev (5-GCAGCAGATATTCCAT
TCAACCAAAG-3) in one PCR; 15 l of the PCR product was used directly for
transformation.
Aspergillus transformation. Transformation protocols basically followed the
procedures published by Tilburn and colleagues (42). Transformants were se-
lected according to the selection marker used (Tables 1 and 2). The transfor-
mants were then checked by PCR and/or dot blot hybridization, as well as by
Southern blot analysis. Replacement of A. nidulans algC by the marker gene was
verified by PCR, using primers ANalgC5_fwd (5-GCTGTTGGAGGCTCTGG
ATAGAAA-3) and ANalgC3_rev (5-GGACAACGTACATGCAACAGGTC
A-3), which anneal to algC 5 and algC 3 sequences not present on the knockout
construct, giving rise to a larger PCR product (4,881 bp) than an intact algC gene
(2,923 bp).
Replacement of A. niger algC by the marker gene used a similar strategy,
employing the algC 5primers alg3_KO_PCR_F (5-CGCCGCATCTACATCC
CCG-3) and alg3_KO_gpdA_R (5-TTGGGACGATGCAAGATATAAACGA
A-3), which anneal to the gpdA promoter of the selection marker on the knock-
out construct. Additionally, the absence of algC coding sequence was verified by
PCR with specific primers and by Southern analysis using an algC open reading
frame fragment of either A. nidulans or A. niger.
Culture conditions. Strains were grown for 20 h at 37°C on 250 ml LB medium
containing supplements according to the auxotrophy markers of the strain and
ammonium tartrate (10 mM) as an additional nitrogen source. The mycelium was
harvested by filtration, washed with 500 ml of tap water, and ground to fine
powder under liquid nitrogen, and the powder was subsequently lyophilized. The
lyophilized biomass was used in glycan digestion and subsequent mass spectrom-
etry (MS) analysis to determine the whole-cell glycosylation.
Glucoamylase production. Strains were grown on Aspergillus complete me-
dium containing supplements according to the auxotrophy markers of the strain
and ammonium tartrate (10 mM) as an additional nitrogen source for 50 h at 200
rpm and 37°C. The mycelium was harvested by filtration and washed with sterile
water. Subsequently, the mycelium was transferred to fresh expression medium
(70 g/liter trisodium citrate dihydrate, 20 ml/liter Aspergillus salt solution, and 10
g/liter maltodextrin, plus the respective supplements and ammonium tartrate [10
mM] as a nitrogen source) and cultivated for about 52 h at 200 rpm and 30°C.
The culture supernatant (containing glucoamylase) was harvested and stored at
80°C. Glucoamylase was purified from the culture supernatant by size exclusion
chromatography (PD-10 columns; Amersham Biosciences), using Tris, pH 8.0,
according to the manufacturer’s manual. The eluate was concentrated via ultra-
filtration (Vivaspin 20-ml concentrator; 5,000 MWCO PES; VivaScience) and
further purified via strong basic anion-exchange chromatography (Vivapure Q
Mini H; VivaScience), using 25 mM Tris, pH 8.0, for equilibration and 1 M
NaCl-25 mM Tris, pH 8.0 for elution. The purified protein was lyophilized.
Total cellular protein extraction and release of N-linked glycan. Total cellular
protein was extracted by dissolving 50 mg of lyophilized and ground cell pellet in
0.5 ml RCM buffer (8 M urea, 360 mM Tris, and 3.2 mM EDTA, pH 8.6) at room
temperature. Cell debris was removed by centrifugation for 15 min at 2,500 rpm
in a Beckmann Coulter Allegra 6 centrifuge. The protein content of the super-
natant was determined by protein assay (Bio-Rad, Hercules, CA). The glycans
were released and separated from the glycoproteins by a modification of previ-
ously reported methods (4, 35). Briefly, 50 g of solubilized proteins of various
samples were adsorbed onto a polyvinylidene difluoride membrane in a 96-well
MultiScreen IP plate (Millipore, Bedford, MA). After the proteins were reduced
and carboxymethylated and the membranes were blocked, the wells were washed
three times with water. The proteins were deglycosylated by the addition of 22 l
of 10 mM NH4HCO3, pH 8.3, containing 1 mU PNGase F (New England
Biolabs). After 16 h at 37°C, the solution containing the glycans was removed to
a clean 96-well plate by centrifugation and evaporated to dryness.
MS analysis. The molecular weights of the glycans were determined using a
Voyager DE PRO linear matrix-assisted laser desorption ionization–time of
flight (MALDI-TOF) mass spectrometer (Applied Biosciences) as described
previously (6). All spectra were generated with the instrument in the positive ion
mode. In this MALDI-TOF ion mode, it is possible that phosphorylated glycans
could not be detected, and the influence of the expression of -1,2-mannosidase
on phosphorylated fungal glycans has not been studied here. All of the masses
obtained in MS analysis are summarized in Table 4.
TABLE 3. Functional-leader–catalytic domain fusion constructs
Construct Leader (amino acid coordinates) Organism (accession no.) Catalytic (amino acid coordinates) Organism (accession no.)
BC10 PpSEC12 (334–363) P. pastoris (AF216960.1) -1,2-Mannosidase (81–541) C. elegans (NM 059715.3)
CD28 ScMNN10 (1–121) S. cerevisiae (YDR245W) -1,2-Mannosidase (187–667) D. melanogaster (X82640)
NA 15 and coNA15 ScMNN9 (1–40) S. cerevisiae (YPL050C) GnTI (38–445) H. sapiens (NM_002406)a
mnnJ-NA mnnJ (1–250) A. niger (DQ841153) GnTI (38–445) H. sapiens (NM_002406)
a Codon optimized with P. pastoris codon bias in coNA.
TABLE 4. Molecular weights of glycans detected by MALDI-TOFa
Proposed structure Composition Theoretical mol wtb Mol wt detected by MALDI-TOFc
Hex3 GlcNAc2 Hex3 933 (949) 934 (950)–936 (952)
Hex4 GlcNAc2 Hex4 1,095 (1,111) 1,096 (1,112)–1,098 (1,114)
Hex5 GlcNAc2 Hex5 1,257 (1,273) 1,258 (1,274)–1,261 (1,277)
Hex6 GlcNAc2 Hex6 1,419 (1,435) 1,419 (1,435)–1,425 (1,441)
Hex GlcNAc2 Hex7 1,581 (1,597) 1,581 (1,597)–1,586 (1,602)
Hex8 GlcNAc2 Hex8 1,743 (1,759) 1,743 (1,759)–1,749 (1,765)
Hex9 GlcNAc2 Hex9 1,905 (1,921) 1,905 (1,921)–1,912 (1,928)
GlcNAcM5 GlcNAc2Man5 GlcNAc 1,460 (1,476) 1,461 (1,477)–1,465 (1,481)
a Molecular weight masses hexose, 180 (162, loss of H2O); GlcNAc, 221 (203, loss of H2O).
b Molecular weight with Na adduct (K adduct in parentheses).
c Molecular weight range from multiple spectra.
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In vitro -1,2-mannosidase digestion. T. reesei -1,2-mannosidase (a gift from
R. Contreras, Unit of Fundamental and Applied Molecular Biology, Department
of Molecular Biology, Ghent University, Ghent, Belgium) digestions were per-
formed as described previously (4).
RNA isolation. Strains were grown overnight on minimal medium containing
the appropriate supplements at 37°C and 180 rpm. The mycelium was harvested
and frozen in liquid nitrogen. RNA was isolated using Trizol according to the
manufacturer’s instructions (Gibco BRL).
qRT-PCR. Quantitative reverse transcription-PCR (qRT-PCR) for gene ex-
pression was performed with Platinum Sybr green qPCR SuperMix-UDG (In-
vitrogen) and a SuperScript III Platinum Two-Step qRT-PCR kit with Sybr green
(Invitrogen) and was carried out on an iCycler thermal cycler with a MyiQ
single-color real-time PCR detection system (Bio-Rad). Reactions were run in
duplicate, and a mean value of the two samples was calculated. The results were
calculated as the relative amount of product adjusted for the level of internal
control amplification (actin mRNA) obtained for the sample. The primers used
for quantification of BC10 in A. nidulans and A. niger were BC10fwd (5-ACT
GCCGGATACTCTGGAATC-3) and trpCrev (5-GATTTCAGTAACGTTA
AGTGGATCC-3), those for CD28 in A. nidulans and A. niger were CD28fwd
(5-TCGCCGAAACGCTTAAGTAC-3) and trpCrev, those for coNA15 in A.
nidulans and A. niger were coNA15 F (5-CAAAACACAATGTCACTTTCTC
TTGTATCCTAC-3) and trpCrev, and those for mnnJ-NA in A. nidulans and A.
niger were GNT F (5-CTTGTATCGTACCGCCTAAGAAAGAACC-3) and
trpCrev. For amplification of the A. niger actin gene (accession no. AAU11333),
the primers actNigR (5-TATCTGAGGGTGAGGATACCACG-3) and act-
NigerF (5-GACAATGGTTCGGGTATGTGC-3) were used. For amplification
of the A. nidulans actin gene (accession no. AN6542.3), the primers actin F
(5-GATCGGTATGGGTCAGAAGGA-3) and actin R (5-CGATGTTGCCG
TACAGATCC-3) were used.
Nucleotide sequence accession numbers. The mnnJ leader sequence has been
deposited with NCBI under accession number DQ841153. The A. niger algC
sequence has been deposited under accession no. DQ841152. The accession
number for A. nidulans algC is AN0104.3.
RESULTS AND DISCUSSION
Expression of functional -1,2-mannosidase fusion proteins
results in trimming of terminal mannose residues to putative
Man5GlcNAc2 structures. -1,2-Mannosidase hydrolyzes ter-
minal 1,2-linked -D-mannose residues in the oligomannose
oligosaccharide Man9GlcNAc2 in a calcium-dependent man-
ner to produce Man8GlcNAc2 in a first step and Man5GlcNAc2
N-glycans on glycosylated proteins in a second step (19). Gen-
eration of Man5GlcNAc2 is one of the critical steps in obtain-
ing complex glycoproteins because this substrate is the precur-
sor for all subsequent downstream processing steps (11). In an
attempt to express functional -1,2-mannosidase in Aspergillus,
cDNAs coding for leader sequences from enzymes known to
target the protein to the ER or Golgi apparatus from S. cer-
evisiae, P. pastoris, or A. niger were combined in the pEKgnopat
Aspergillus expression vector (see Materials and Methods) with
different catalytic domains derived from Caenorhabditis el-
egans, Drosophila melanogaster, Mus musculus, and T. reesei.
Leader sequences from putative A. niger orthologues of S.
cerevisiae Gls1p, Mns1p, Mnn10p, Mnn11p, and Anp1p were
identified and cloned by similarity searches against an A. niger
sequence database (data not shown). Among all putative A.
niger leaders, only the Mnn10p orthologue was found to be
functional in combination with heterologous catalytic domains
(see below). The combinatorial fusion constructs were individ-
ually transformed into A. niger strain T2 and A. nidulans strain
YR23.5 (in A. nidulans, only constructs BC10 and CD28 were
transformed), and the integration events were verified by PCR
and Southern blotting (results not shown). The copy numbers
of constructs integrated into the genome varied from one copy
to several copies in our Southern analysis, potentially influenc-
ing the expression levels of the integrated genes. We deter-
mined the expression levels in at least two single-copy strains
of each transformation event in Aspergillus complete medium
(36) by qRT-PCR. Expression levels were monitored by a
combination of -1,2-mannosidase-specific and trpC termina-
tor-specific primers, and the transcript levels obtained were
normalized to the A. nidulans or A. niger actin gene acnA (see
Materials and Methods). Additionally, the actin-normalized
expression levels of the transgenes were compared with the
actin-normalized mRNA levels of the endogenous gpdA genes
of A. niger or A. nidulans. In single-copy transformants, similar
mRNA levels (with differences of less than 20%) were re-
corded (data not shown). Such strains were selected for further
analysis, for which the cultures were processed as described in
Materials and Methods, and whole-cell glycans were released
by PNGase digestion and analyzed by MALDI-TOF analysis.
Structure assignments were based on the masses (summa-
rized in Table 4) and sensitivity to -1,2-mannosidase. How-
ever, we cannot rule out the possibility of other hexoses. For
example, in A. niger N-linked glycans, the presence of galactose
in a galactofuranose conformation has been established (44,
46). In this work, we did not analyze for their appearance by
digestion with alternative mannosidases, such as an -1,2/3/6-
mannosidase.
Therefore, the masses of N-linked glycans released by
PNGase F digestion of proteins obtained by MALDI-TOF are
referred to as hexoses. For example, in the figures, we refer to
a GlcNAc2Hex6 structure as Hex6.
The BC10 construct (a P. pastoris SEC12 leader fused to a C.
elegans -1,2-mannosidase lacking a transmembrane domain
[Table 3]) was the only one found to be functional in A. niger
and resulted in a considerable shift of glycan composition from
mainly Man8GlcNAc2 (Fig. 1A, right) to strongly elevated
amounts of Man5GlcNAc2 (Fig. 1B, right). All other constructs
were not functional in modifying the N-glycan masses; one
example is shown in Fig. 1C, right, for the CD28 fusion con-
struct (an S. cerevisiae MNN10 leader fused to a D. melano-
gaster -1,2-mannosidase lacking a transmembrane domain).
Of these two fusion proteins, only the expression of BC10
resulted in a different glycosylation pattern at the level of
whole-cell glycans in A. nidulans. Figure 1, left, compares the
glycan masses obtained by MALDI-TOF analysis for the A.
nidulans recipient strain YR23.5 (Fig. 1A) with the spectra
obtained from the strain expressing the BC10 construct (Fig.
1B) and an example of a typical spectrum obtained from a
strain carrying a nonfunctional fusion construct (CD28) (Fig.
1C). The mass spectrum of BC10 clearly shows elevated masses
consistent with Man5GlcNAc2 structures. Ions appearing with
low abundance between Hex6 and Hex7 that have masses
similar to GlcNAcMan5GlcNAc2 in Fig. 1A and B are probably
a matrix artifact and not N-linked glycans. The glycan patterns
of A. nidulans (Fig. 1D, left) and A. niger (Fig. 1D, right), which
were obtained after in vitro digestions using purified -1,2-
mannosidase on whole-cell extracts, show an almost complete
reduction of any N-glycan other than Man5GlcNAc2, and this
result shows that the in vivo functionality of the -1,2-manno-
sidase fusion constructs is only partial.
In addition to whole-cell glycan analysis, the N-glycans of a
prominent secreted A. niger protein were analyzed. Glucoamy-
lase, an enzyme secreted under starch or maltodextrin induc-
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tion, was purified (see Materials and Methods) and analyzed
for glycan composition. The glycan pattern of glucoamylase
was comparable to that of the whole-cell glycans, with a shift
from Man8GlcNAc2 to high levels of Man5GlcNAc2 (Fig. 2).
Interestingly, only one construct (BC10) was shown to be
functional in both Aspergillus species at the level of whole-cell
glycans (A. nidulans and A. niger) and on secreted glucoamy-
lase (A. niger). As in P. pastoris, the catalytic domain of C.
elegans worked best in both Aspergillus species. In P. pastoris,
when combined with the S. cerevisiae leaders MNS1 and
MNN10, the catalytic domain of C. elegans produced predom-
inantly Man5GlcNAc2 on the Pichia reporter protein K3 (6). A
slightly lower rate, as estimated from MALDI-TOF analysis,
was observed in A. niger. Other constructs shown to be func-
FIG. 1. Whole-cell N-glycan analysis of Aspergillus strains expressing engineered -1,2-mannosidases. The images on the left compare whole-
cell N-glycans from A. nidulans recipient strain YR23.5 (A) with strain YR23.5-BC10 (B) and strain YR23.5-CD28 (C). The images on the right
show whole-cell N-glycan spectra obtained from A. niger recipient strain T2 (A), strain T2-BC10 (B), and strain T2-CD28 (C). (D) N-glycan spectra
obtained after in vitro PNGase F digestion of A. nidulans (left) or A. niger (right) whole-cell extracts with -1,2-mannosidase. Preparation and
analysis of N-glycans was performed as described in Materials and Methods. Structure assignments in this figure and all subsequent figures are
based on MALDI-TOF masses (m/z) of individual PNGase F-released ions sensitive to -1,2-mannosidase, and the relative intensities of the masses
are shown (% intensity).
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tional in Pichia were not successful in Aspergillus. Even though
previous studies established a correlation between certain do-
mains and targeting events, there is currently no tool available
that allows one to predict the behavior of a given targeting
peptide across different hosts. Accordingly, we were not able to
predict from comparison of the primary protein sequences of
functional versus nonfunctional mannosidases which of the
constructs tested would work in Aspergillus.
Human -1,2-N-acetylglucosaminyltransferase I (GNT I) is
functional in vivo. The transfer of N-acetyl-D-glucosamine to
Man5GlcNAc2 substrates generated by the previous Man8GlcNAc2-
to-Man5GlcNAc2 trimming step was investigated. The GNT I
enzyme localizes to the luminal face of the Golgi apparatus,
allowing the sequential processing of glycoproteins as they are
shuttled through the secretory pathway. In one construct, the
catalytic domain of human GNT I (abbreviated as NA) was
fused to the MNN9 leader (abbreviated as 15) from S. cerevi-
siae to yield construct NA15. In a second construct, a fungal
codon-optimized form (coNA; see Materials and Methods for
details) was combined with the same MNN9 leader to yield
construct coNA15. Yet another construct used a leader se-
quence from a putative A. niger gene with similarity to the S.
cerevisiae MNN10 gene, designated mnnJ according to the As-
pergillus nomenclature (for the mnnJ accession number and all
construct details, see Materials and Methods and Table 3).
Fusion of the mnnJ leader sequence with NA yielded mnnJ-
NA, which was, like all the other fusion constructs, subse-
quently integrated into the same expression vector backbone.
These expression vectors were stably introduced by transfor-
mation into A. nidulans and A. niger strains already carrying the
BC10 -1,2-mannosidase construct, which showed the highest
in vivo activity. Integration events were verified by PCR and
Southern analysis, and expression of the constructs was tested
by qRT-PCR (see Materials and Methods).
Whole-cell N-glycan analysis of A. niger BC10-transformed
strains revealed that expression of the fusion construct
coNA15 (Table 3) resulted in efficient transformation of
Man5GlcNAc2 to GlcNAcMan5GlcNAc2 N-glycans, as seen
from mass analysis (Fig. 3, right). It is intriguing that in the A.
niger T2-BC10 recipient strain a considerable portion of higher-
mannose N-glycans, such as Man6GlcNAc2, Man7GlcNAc2,
and Man8GlcNAc2, still existed in parallel with a large amount
of Man5GlcNAc2 (Fig. 3A, right). In the strain additionally
expressing the GNT I enzyme (Fig. 3B, right), these higher-
mannose glycans were significantly reduced.
The N-glycans released from the purified A. niger glucoamylase
were subsequently analyzed in strains T2-BC10-coNA15 und T2-
BC10-mnnJ-NA. The glycan pattern of glucoamylase was compa-
rable to that of the whole-cell glycans, with a shift from
Man5GlcNAc2 to GlcNAcMan5GlcNAc2 (Fig. 4). Whereas at the
level of whole-cell glycans, the construct mnnJ-NA was not func-
tional at all (Fig. 3C, right), some GlcNAc transfer was detected
on glucoamylase (Fig. 4C).
On glucoamylase of A. niger strain T2-BC10-coNA15, predom-
inantly masses corresponding to GlcNAcMan5GlcNAc2 were
found, but (Man5-Man9)GlcNAc2 and a mass consistent with
GlcNAcMan6GlcNAc2 were also detected. It remains to be de-
termined whether introduction of a GlcNAc transporter would
shift the glycosylation of secreted protein in A. niger toward
GlcNAcMan5GlcNAc2, as was reported for P. pastoris (6).
Whole-cell glycan analysis of the transformed strains, along
with the A. nidulans BC10 recipient strain (Fig. 3A, left), was
carried out by mass spectrometry following glycan digestions.
Of all transformants tested, the strain carrying construct
coNA15 showed a new peak corresponding to the mass of
GlcNAcMan5GlcNAc2 structures (Fig. 3B, left). Interestingly,
the construct mnnJ-NA showed some activity in A. nidulans
(Fig. 3C, left) but no activity in A. niger.
MnnJ is the putative orthologue of S. cerevisiae Mnn10p,
which functions in a complex with MNN9p in a subunit of the
yeast Golgi apparatus mannosyltransferase complex, also con-
taining Anp1p, Mnn11p, and Hoc1p, that mediates elongation
of the polysaccharide mannan backbone (22). Interestingly, the
FIG. 2. MALDI-TOF spectra of N-glycans derived from purified A.
niger glucoamylase of the recipient strain T2 (A), strain T2-BC10 (B),
or strain T2-CD28 (C).
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MnnJ leader sequence was the only fungal leader with signif-
icant activity out of five putative proteins derived from the
Golgi apparatus mannosyltransferase complex.
One GNT I construct was shown to be particularly active in
A. niger and to shift the equilibrium of the enzymatic reaction
toward GlcNAcMan5GlcNAc2. Interestingly, in the strain ex-
pressing only -1,2-mannosidase from the BC10 construct, a
considerable number of Man7GlcNAc2 and Man8GlcNAc2 gly-
can structures still existed in parallel with the large amount of
Man5GlcNAc2 (Fig. 3A, right), but in the strain additionally
expressing the GNT I enzyme (Fig. 3B, right), these higher-
mannose structures were almost completely lost. These results
suggest that removal of Man5GlcNAc2, produced by -1,2-
mannosidase, by GNT I, which uses Man5GlcNAc2 as a
FIG. 3. Whole-cell N-glycan analysis of Aspergillus strains expressing engineered GNT I. (A, B, and C) The images on the left compare
whole-cell N-glycans from A. nidulans strain YR23.5-BC10, which served as a recipient for the GNT I constructs (A) (shown in Fig. 1B, left, and
repeated here for clarity), with strain YR23.5-BC10-coNA15 (B) and strain YR23.5-BC10-mnnJ-NA (C). The images on the right show whole-cell
glycan spectra for A. niger strain T2-BC10, which served as a recipient strain for the GNT I constructs (A), compared to N-glycans obtained from
strain T2-BC10-coNA15 (B) and strain T2-BC10-mnnJ-NA (C). (D) Schematic diagram representing the function of GNT I, which generates
GlcNAcMan5GlcNAc2 structures by the addition of one GlcNAc moiety on Man5GlcNAc2. GlcNAc residues are represented by squares and
mannose (hexose) residues by circles.
1082 KAINZ ET AL. APPL. ENVIRON. MICROBIOL.
substrate, shifts the substrate-product equilibrium for -1,2-
mannosidase, which in turn results in a more active -1,2-
mannosidase enzyme along the glycosylation line. Additionally
or alternatively, removal of Man5GlcNAc2 could also remove
the substrate for alternative resident glycosyltransferases. More-
over, in a GNT I strain expressing a nonfunctional -1,2-manno-
sidase fusion construct (e.g., T2-CD28), no GlcNAcMan5GlcNAc2
was detected, and therefore, it seems that the endogenous A.
niger -1,2-mannosidase is not sufficient to provide enough
substrate for a functional GNT I enzyme. As already seen with
the -1,2-mannosidase fusion construct BC10, the GNT I fu-
sion construct already shown to be functional in Pichia pastoris
also worked best in Aspergillus. In contrast to the -1,2-man-
nosidase, which showed only partial activity in Aspergillus, the
GNT I construct led almost exclusively to GlcNAcMan5GlcNAc2, as
reported for P. pastoris (6). Our results on whole-cell glycan
structures also suggest that the -1,2-mannosidase fusion con-
struct BC10 is correctly localized in Aspergillus and that -1,2-
mannosidase trimming occurs in the ER and early Golgi ap-
paratus and not through secreted -1,2-mannosidase in the
medium. This was of concern, since leakage of -1,2-manno-
sidase into the medium was reported by other groups (5, 6).
Generation of Man3GlcNAc2 structures by knockout of the
algC gene. The formation of N-glycosidic linkages of glycopro-
teins involves the ordered assembly of the common Glc3Man9
GlcNAc2 core oligosaccharide on the lipid carrier dolichyl pyro-
phosphate. Whereas early mannosylation steps occur on the
cytoplasmic side of the ER with GDP-Man as the donor, the
final reactions from Man5GlcNAc2-PP-Dol to Man9GlcNAc2-
PP-Dol on the luminal side use Dol-P-Man. The ALG3 gene
encodes the Dol-P-Man:Man5GlcNAc2-PP-Dol mannosyltrans-
ferase, which converts Man5GlcNAc2-Dol-PP to Man6GlcNAc2-
Dol-PP. Knockout of ALG3 in S. cerevisiae and P. pastoris leads to
specific Man5GlcNAc2 structures, which can be trimmed to
Man3GlcNAc2 by -1,2-mannosidase (Fig. 5). We have previ-
ously shown that the distinct alg3 Man5GlcNAc2 can be
trimmed by -1,2-mannosidases to obtain paucimannose
FIG. 4. N-glycan analysis of purified A. niger glucoamylase from
strain T2-BC10, which served as a recipient for the GNT I constructs
(A) (shown in Fig. 2B and repeated here for clarity), compared to
strains T2-BC10-coNA15 (B) and T2-BC10-mnnJ-NA (C).
FIG. 5. The function of Alg3p. (A) The yeast ALG3 gene encodes
the Dol-P-Man:Man5GlcNAc2-PP-Dol mannosyltransferase, which
converts Man5GlcNAc2-Dol-PP to Man6GlcNAc2-Dol-PP. (B) Knock-
out of ALG3 leads to Man5GlcNAc2 structures, which can be trimmed
to Man3GlcNAc2 by -1,2-mannosidase.
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Man3GlcnNAc2. Paucimannose then can serve as a substrate
for GnT I. (7).
We cloned the ALG3 orthologues of both, A. nidulans and A.
niger (see Materials and Methods) and designated the corre-
sponding genes algC. Alignments of the A. nidulans (AN0104.2),
A. niger (DQ841152), and A. terreus (EAU37037) AlgC proteins
with S. cerevisiae Alg3p (YBL082C) showed high similarity among
the three proteins only in the N-terminal part. The A. nidulans
protein is around 200 amino acids smaller than the yeast Alg3p
and showed a similarity score of only 8e-33 in a BLAST search
against the A. nidulans genome database (http://www.broad.mit
.edu) using S.c.Alg3p as the in silico probe. High overall similarity
can be observed only among the putative AlgC proteins of fila-
mentous fungi (e.g., A. oryzae, Aspergillus fumigatus, and Neuros-
pora crassa), but yeasts and basidiomycetes show only very limited
overall similarity in their putative Dol-P-Man:Man5GlcNac2-PP-
Dol mannosyltransferases (not shown).
Using roughly 1 kb of the nucleotide sequence upstream and
downstream of the algC open reading frame, we generated by
hybrid PCR two sets of deletion constructs. One construct
carried between the upstream and downstream sequences the
auxotrophic marker gene argB (for A. nidulans), while the
other harbored the dominant hygromycin resistance marker
gene hygB (for A. niger). We then generated algC knockout
strains (algC) for both organisms. Morphologically, A. nidu-
lans strains YR23.5 and YR23.5-algC did not show any sig-
nificant differences. The knockout strain did not show any
growth defects on minimal or complete medium and sporu-
lated as well as the recipient and other algC strains (not
shown). Analysis of the whole-cell glycans of the A. nidulans
strain YR23.5-algC showed a shift of the whole-cell glycan
pattern to lower-mannose-type glycosylation. Additional masses,
such as Man3GlcNAc2 and Man4GlcNAc2, previously not seen
in the parental strain were observed (Fig. 6A). Structures
larger than GlcNAcMan3GlcNAc2 could be the result of en-
dogenous glycosyltransferase activity capping the free -1,6-
mannose arm. However, knockout of algC efficiently inhibited
core oligosaccharide assembly in A. nidulans, confirming that
indeed we had for the first time cloned and deleted an ALG3
homologue of a filamentous fungus. We then tested whole-cell
glycans in the A. niger T2-algC knockout strain. As in A.
nidulans, the lack of AlgC activity led to a shift of the whole-
cell glycan pattern to lower-mannose-type glycosylation, like
Man3GlcNAc2 and Man4GlcNAc2 (not shown). In vitro diges-
tion of N-glycans released from the A. niger algC strain with
purified -1,2-mannosidase led to an almost complete trim-
ming of the Man4GlcNAc2, Man5GlcNAc2, and Man6GlcNAc2
structures to Man3GlcNAc2 (Fig. 6C). When N-glycans re-
leased from glucoamylase purified from this strain were ana-
lyzed (not shown), the mass spectra showed a peak composi-
tion similar to that seen for A. niger whole-cell glycans, i.e., a
loss of higher masses and the appearance of masses corre-
sponding to Man3GlcNAc2 to Man6GlcNAc2 (Fig. 6B).
Knockout of algC (AN0104.4) in A. nidulans led to some
Man3GlcNAc2, in addition to Man4GlcNAc2 and Man5GlcNAc2,
which was the dominant glycan, as well as Man6GlcNAc2. In A.
niger, the knockout of algC also led to the generation of masses
consistent with Man3GlcNAc2 and Man4GlcNAc2, structures not
present in the parent strain (compare Fig. 1). Similarly to A.
nidulans, Man5GlcNAc2 and Man6GlcNAc2 were additional gly-
cans, in this case dominated by Man6GlcNAc2. In vitro digestion
of T2-algC whole-cell glycans led almost exclusively to
Man3GlcNAc2 paucimannose glycans. Previously observed larger
glycan masses recalcitrant to in vitro -1,2-mannosidase treat-
ment in a P. pastoris alg3 och1 strain (7) were not detected in
A. niger. Such larger structures can be formed by endogenous
glycosyltransferases, which may add hexoses to various glycan
structures (such as the unusual algC glycan created here) in vivo.
Digestion of N-linked glycans derived from the algC strain with
purified -1,2-mannosidase led to an almost complete trimming
of the masses consistent with Man4GlcNAc2, Man5GlcNAc2, and
FIG. 6. Whole-cell N-glycan analysis of Aspergillus strains lacking
AlgC activity. (A and B) Whole-cell N-glycan structures of the A.
nidulans strain YR23.5-algC (A) and A. niger strain T2-algC (B).
(C) N-glycan spectrum obtained after in vitro digestion of A. niger
T2-algC whole-cell extracts with purified -1,2-mannosidase.
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Man6GlcNAc2 structures to Man3GlcNAc2. Similar larger-size
oligosaccharides were observed after the cloning and deletion of
the ALG3 gene in the methylotrophic yeast P. pastoris. This find-
ing implies the existence of endogenous glycosyltransferases ca-
pable of transferring sugars to the canonical alg3 Man5 N-glycan
(7). Subsequent experiments, such as the analysis of lipid-linked
oligosaccharides, should allow the elucidation of these novel
structures and will in turn provide a deeper understanding of the
substrate specificity of glycosyltransferases residing in the secre-
tory pathway in Aspergillus.
In sum, the findings presented here suggest, as also previ-
ously demonstrated for the methylotrophic yeast P. pastoris (4),
that the deletion of algC can indeed provide a promising route
in Aspergillus for the addition of one additional GlcNAc resi-
due to produce GlcNAcMan3GlcNAc2, and hence, to drive
further the production of humanized complex glycoproteins in
filamentous fungi.
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